Clinical Trial Update: Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose temozolomide with metformin or placebo in recurrent or refractory glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• metformin (metformin)
• temozolomide (low-dose) (temozolomide)

Snippet

Sponsor: Yong-Kil Hong | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED